Informed-money record

DYN · Dyne Therapeutics, Inc.

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

6

Bearish filings

186

Named actors

15

Disclosed $ (bull / bear)

$241K / $197.0M

Recent disclosures

25 of 192 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-07Director Rhodes Jason Psold$118KSEC ↗
2026-07-07Director Rhodes Jason Psold$276KSEC ↗
2026-07-07Director Rhodes Jason Psold$1.1MSEC ↗
2026-07-07Director Rhodes Jason Psold$351KSEC ↗
2026-07-07Director Rhodes Jason Psold$1.4MSEC ↗
2026-07-07Director Rhodes Jason Psold$699KSEC ↗
2026-07-07Director Rhodes Jason Psold$2.9MSEC ↗
2026-07-07Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund II, LPfiled notice to sell$1.8MSEC ↗
2026-07-07Shareholder (via Merrill Lynch) Atlas Venture Fund XI, LPfiled notice to sell$3.5MSEC ↗
2026-07-07Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund I, LPfiled notice to sell$1.4MSEC ↗
2026-07-07Shareholder (via Merrill Lynch) ATLAS VENTURE ASSOCIATES XI, L.P.filed notice to sell$114KSEC ↗
2026-07-06Director Rhodes Jason Psold$2.3MSEC ↗
2026-07-06Director Rhodes Jason Psold$2.9MSEC ↗
2026-07-06Director Rhodes Jason Psold$5.8MSEC ↗
2026-07-06Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund II, LPfiled notice to sell$2.9MSEC ↗
2026-07-06Shareholder (via Merrill Lynch) Atlas Venture Fund XI, LPfiled notice to sell$5.8MSEC ↗
2026-07-06Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund I, LPfiled notice to sell$2.3MSEC ↗
2026-06-29Director Rhodes Jason Psold$860KSEC ↗
2026-06-29Director Rhodes Jason Psold$1.1MSEC ↗
2026-06-29Director Rhodes Jason Psold$2.2MSEC ↗
2026-06-29Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund I, LPfiled notice to sell$852KSEC ↗
2026-06-29Shareholder (via Merrill Lynch) Atlas Venture Fund XI, LPfiled notice to sell$2.2MSEC ↗
2026-06-29Shareholder (via Merrill Lynch) Atlas Venture Opportunity Fund II, LPfiled notice to sell$1.1MSEC ↗
2026-06-26Director Rhodes Jason Psold$1.7MSEC ↗
2026-06-26Director Rhodes Jason Psold$1.4MSEC ↗

167 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals